OPTIDART
LIVE

Serial Number

79264896

Owner

Genexine, Inc.

Attorney

James R Menker

Filing Date

May 17, 2019

Add to watchlist:

No watchlists yet
View on USPTO

OPTIDART Trademark

Serial Number: 79264896 • Registration: 6599482

OPTIDART is a trademark filed by Genexine, Inc. on May 17, 2019. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Genexine, Inc. (16 trademarks)

(Magokdong, Bio Innovation Park) 172,

Entity Type: 98

Trademark Details

Filing Date

May 17, 2019

Registration Date

December 28, 2021

Published for Opposition

October 12, 2021

Goods & Services

Pharmaceutical preparations for regulating the immune system; pharmaceutical products for the treatment of viral diseases; vaccines; adjuvants for use with vaccines; vaccine preparations; anti-inflammatories; pharmaceutical preparations and compositions for the treatment and prevention of cancer; pharmaceutical preparations for the treatment of inflammatory diseases; nucleic acid sequences for medical and veterinary purposes; diagnostic preparations for medical purposes for detecting mutation in prion genes; chemical preparations for use in DNA analysis for medical purposes; reagents for use in medical genetic testing; human vaccine preparations; pharmaceutical preparations for the treatment of cervical intraepithelial neoplasia; pharmaceutical preparations for the treatment of immune system related diseases and disorders; anti-asthmatic agents, namely, pharmaceutical preparations for the treatment of asthmatic disorders; dermatological pharmaceutical products; antibiotic preparations; biological preparations, namely, antibody fusion proteins for the treatment of cancer

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Feb 7, 2025 NREP
CHANGE OF NAME/ADDRESS REC'D FROM IB
Nov 28, 2024 ADCH
FINAL DECISION TRANSACTION PROCESSED BY IB
Jul 5, 2022 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jun 10, 2022 FICS
FINAL DISPOSITION PROCESSED
Jun 9, 2022 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Mar 28, 2022 FICR
REGISTERED-PRINCIPAL REGISTER
Dec 28, 2021 R.PR
NOTIFICATION PROCESSED BY IB
Oct 24, 2021 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 12, 2021 NPUB
PUBLISHED FOR OPPOSITION
Oct 12, 2021 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sep 22, 2021 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Sep 22, 2021 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 22, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 6, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 26, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 26, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 26, 2021 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 14, 2021 GNRN
NON-FINAL ACTION E-MAILED
Jul 14, 2021 GNRT
NON-FINAL ACTION WRITTEN
Jul 14, 2021 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
May 26, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 26, 2021 CRFA
ASSIGNED TO LIE
May 25, 2021 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
May 19, 2021 ERSI
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jan 30, 2021 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 13, 2021 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jan 13, 2021 OPNR
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Nov 12, 2020 RCSC
ASSIGNED TO LIE
Nov 12, 2020 ALIE
NEW REPRESENTATIVE AT IB RECEIVED
May 28, 2020 NREP
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Apr 1, 2020 GNS3
LETTER OF SUSPENSION E-MAILED
Apr 1, 2020 GNSL
SUSPENSION LETTER WRITTEN
Apr 1, 2020 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 7, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 7, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 7, 2020 TROA
REFUSAL PROCESSED BY IB
Sep 28, 2019 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 11, 2019 RFCS
REFUSAL PROCESSED BY MPU
Sep 11, 2019 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 27, 2019 RFCR
NON-FINAL ACTION WRITTEN
Aug 26, 2019 CNRT
APPLICATION FILING RECEIPT MAILED
Aug 24, 2019 MAFR
ASSIGNED TO EXAMINER
Aug 20, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 20, 2019 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Aug 8, 2019 REPR